YAMADA Yuji | Hanno Research Center, Taiho Pharmaceutical Co., Ltd
スポンサーリンク
概要
Hanno Research Center, Taiho Pharmaceutical Co., Ltd | 論文
- Cellular and Biochemical Mechanisms of the Resistance of Human Cancer Cells to a New Anticancer Ribo-nucleoside, TAS-106
- In vitro Antitumor Activity of TAS-103, a Novel Quinoline Derivative That Targets Topoisomerases I and II
- A Dual Topoisomerase Inhibitor, TAS-103, Induces Apoptosis in Human Cancer Cells
- Sensitivity, of Human Cancer Cells to the New Anticancer Ribo-nucleoside TAS-106 Is Correlated with Expression of Uridine-cytidine Kinase 2